PHARMACOKINETICS AND METABOLISM OF 2-CHLORO-11-(2-DIMETHYLAMINOETHOXY)-DIBENZO[B,F]THIEPINE (ZOTEPINE) IN RAT, MOUSE, DOG AND MAN

被引：0

|

作者：

NODA, K

SUZUKI, A

OKUI, M

NOGUCHI, H

NISHIURA, M

NISHIURA, N

机构：

[1] OSAKA KEIHAN HOSP,OSAKA,JAPAN

[2] OSAKA MED COLL,DEPT PSYCHIAT,TAKATSUKI,OSAKA 569,JAPAN

来源：

ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 1979年 / 29-2卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

收藏

页码：1595 / 1600

页数：6

相关论文

共 26 条

[21] 2-CHLORO-11(4'-METHYLPIPERAZINO)-DIBENZO- B,F! 1,4!-OX-AZEPINE), (SUM 3170), A NEW NEUROLEPTIC SUBSTANCE RESULTS OF AN INTERCLINICAL STUDY
ANGST, J
CORNU, F
HEIMANN, H
POLDINGE.W
STEINER, H
ARZNEIMITTEL-FORSCHUNG, 1970, 20 (07): : 967 - &
[22] SPECIES-DIFFERENCES IN DISPOSITION AND METABOLISM OF 6,11-DIHYDRO-11-OXODIBENZ[BE]OXEPIN-2-ACETIC ACID (ISOXEPAC) IN RAT, RABBIT, DOG, RHESUS-MONKEY, AND MAN
ILLING, HPA
FROMSON, JM
DRUG METABOLISM AND DISPOSITION, 1978, 6 (05) : 510 - 517
[23] METABOLISM AND PHARMACOKINETICS OF PIPROZOLINE IN RAT, DOG AND MAN .2. DETERMINATION OF METABOLIC PROFILES WITH ACID OF AN HPLC-RADIOACTIVITY DETECTION SYSTEM FOLLOWING DIRECT INJECTION OF URINE AND BILE ONTO A REVERSED-PHASE COLUMN
HODENBERG, AV
KLEMISCH, W
VOLLMER, KO
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1977, 27-1 (NB2): : 508 - 511
[24] THE DISPOSITION AND METABOLISM OF 5-(4,5-DIHYDRO-2-PHENYLBENZ[E]INDOL-3-YL)SALICYLIC ACID (FENDOSAL) IN THE RAT, MOUSE, RABBIT, DOG, RHESUS-MONKEY, AND MAN
WARRANDER, A
METCALF, R
FROMSON, JM
DRUG METABOLISM AND DISPOSITION, 1981, 9 (02) : 161 - 167
[25] CONFORMATIONS OF SOME SEMI-RIGID NEUROLEPTIC DRUGS .2. CRYSTAL-STRUCTURES OF RACEMIC AND OF (+)-(S)-OCTOCLOTHEPIN[2-CHLORO-10,11-DIHYDRO-11-(4-METHYLPIPERAZIN-1-YL)DIBENZO[B,F]THIEPIN] AND ABSOLUTE-CONFIGURATION OF LATTER
JAUNIN, A
PETCHER, TJ
WEBER, HP
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1977, (02): : 186 - 190
[26] Liquid chromatographic analysis in mouse, dog and human plasma; stability, absorption, metabolism and pharmacokinetics of the anti-HIV agent 2-chloro-5-(2-methyl-5,6-dihydro-1,4-oxathiin-3-yl carboxamido)isopropylbenzoate (NSC 615985, UC84)
Nomeir, AA
McComish, MF
Ferrala, NF
Silveira, D
Covey, JM
Chadwick, M
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 17 (01) : 27 - 38